Related Image: Recognizing the Importance of Breast Cancer Awareness |
(Date:11/24/2009)... Health Care Reform creates n...such as managing chronic care treatment—and ... Alpharetta, GA (Vocus) Nov...ing health care reform is controversial, to say th..., legislators and policy makers all weighing in wi...
(Date:11/24/2009)... The GeoPense World Volunteer...his project applies the Quantum Monte Carlo method...to simulate molecules important in life science re...olding simulation), Einstein@home (gravity wave de... currently underway. , (P...
(Date:11/24/2009)..., WASHINGTON,Nov.24/PRNewswire-USNewswire/--Newp...nearly4millionAmericansinfectedwithchronichepatiti...houldbeawake-upcallthatCongressneedstomoveurgently...ction,research,andsurveillanceefforts,the National...eNVHRwarnsthatwithoutcongressionalaction,millionso...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire/--TheLupusFoundat...ebrate35yearsofsuccessprovidingfreeday-to-dayeduca...sandtheirfamiliesinthegreaterD.C.area.LFAGW,s35thA...:00p.m.-2:30p.m.atB.Smith,s,50MassachusettsAve.,N....icketsareavailableat$100each.Tablesponsoropportuni...
(Date:11/23/2009)... open on-the-job interaction might ease the proble...HealthDay News) -- Men who bottle up their anger o...r hearts, a new Swedish study indicates. , Men ...t over conflicts with a fellow worker or superviso...ttack or die of heart disease as those who vented ...
Breaking Medicine News(10 mins):Health News:Jackson & Coker Industry Report Addresses Health Care Reform 2Health News:Jackson & Coker Industry Report Addresses Health Care Reform 3Health News:GeoPense Announces it has Joined QMC@home Project 2Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3...diosurgery solutions from Elekta discussed at the...2009 American Association of Neurological Surgeons...onvention Center, Elekta customers and personnel w...ologists today. , , Local Control of Brain Mets ...
... of a Swine Flu Vaccine in a Few Weeks , , MERIDE...PSC), a privately-owned biopharmaceutical company ...lders elected a new slate of members to the Compan...ince July 1996, President since 1998 and a Directo...
...s Wisconsin residents Access to Nursing Home, As... Costs in Nearly Every Zip Code Statewide , , RI...e in Wisconsin is rising at a rate outpacing infla...e current economic downturn has led to a decline i...
...s Texans Access to Nursing Home, Assisted Living, ...y Every Zip Code Statewide , , RICHMOND, Va., Apr...rising at a rate outpacing inflation, putting sign... downturn has led to a decline in home values and ...
...and encouragement take the worry away, researcher ...ws) -- Women were 10 times more likely to do breas...intervention program that included one counseling ...ram screening in the previous two months. They wer...
...s Ohio Residents Access to Nursing Home, Assisted ...in Nearly Every Zip Code Statewide , , RICHMOND, ...o is rising at a rate outpacing inflation, putting...nomic downturn has led to a decline in home values...
Other Medicine News:Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 2Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 3Health News:Protein Sciences Corporation Appoints New Board of Directors 2Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wisconsin Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Breast Self-Exam Rates Go Up With Counseling 2Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Ohio Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4(Date:11/23/2009).../--LightSciencesOncology,Inc.(LSO)todayannouncedth...toanewlycreatedseatonitsboardofdirectors.Mr.Seddig...panies,includingElekta,tomarketleadership. ,, "...thinbusinessdevelopmenttotheboard,"saidLSO,sChairm...ncancer-therapybusinessdevelopment.Hehasoverseenth...
(Date:11/23/2009)...e-FirstCall/-- CumberlandPharmaceuticalsInc. (CPIX...studyevaluatingthesafetyandefficacyofCaldolor( ibu...patients. ,, Statisticalsignificancewasachieved...overthefirst24hoursoftreatment.Thestudyevaluated61...ingmorethan10percenttotalbodysurfacearea.Otherpart...
(Date:11/23/2009)...e-FirstCall/--WoundManagementTechnologies,Inc.,(OT...altymedicalproducts,announcedthatithasfileditQ3200...ementbusinessupdatetoillustratethedevelopmentsduri...33.5%to$102,926vs.Q32008salesof$77,084. , Sha....Q32008shareholderequityof$(321,257) , Totala...
Breaking Medicine Technology:Light Sciences Oncology Elects Akbar Seddigh, Chairman of Elekta AB to Its Board of Directors 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 1Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 2Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 3Outcomes Registry in Heart Attack Patients to Generate Numerous Studies 3B Data Quality Ensured Through Velos Clinical Research Management System 5317 4Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 1Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material 5315 2Survivors of childhood cancer less likely to marry 10291 1Survivors of childhood cancer less likely to marry 10291 2...Data to the NEBIDO NDA PDUFA Date Exp...Jan. 22 Indevus,Pharmaceuticals, Inc. (Nasdaq: I...from its Phase III program for NEBIDO (testosteron...one therapy under development for the,treatment of... has been,filed with the U.S. Food and Drug Admini...
...te Anti-Tumor Activity of Bavituximab in ... TUSTIN, Calif., Jan. 22 Peregrine,Pharmaceutical...maceutical,company developing monoclonal antibodie...s (HCV) infection, today announced that its Phase ...nation with chemotherapy in,patients with non-smal...
Other Medicine Technology:Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 2Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 3Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 4Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 5Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 6Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4The Natural-Hip Family - Revision/Trauma Nonporous CoCr
MARATHON Cross Linked Polyethylene Acetabular Liner
Ringloc Acetabular Liners
Olympia Total Shoulder System
Medicine Products: